The global Specimen Collection Card market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Specimen Collection Card is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Specimen Collection Card is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Specimen Collection Card is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Specimen Collection Card players cover QIAGEN, PerkinElmer Inc., Euroimmun, Eastern Business Forms, Inc., Ahlstrom, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Specimen Collection Card Industry Forecast” looks at past sales and reviews total world Specimen Collection Card sales in 2024, providing a comprehensive analysis by region and market sector of projected Specimen Collection Card sales for 2025 through 2031. With Specimen Collection Card sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Specimen Collection Card industry.
This Insight Report provides a comprehensive analysis of the global Specimen Collection Card landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Specimen Collection Card portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Specimen Collection Card market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Specimen Collection Card and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Specimen Collection Card.
This report presents a comprehensive overview, market shares, and growth opportunities of Specimen Collection Card market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blood
Saliva
Urine
Others
Segmentation by Application:
New Born Screening
Infectious Diseases Testing
Therapeutic Drug Monitoring
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
QIAGEN
PerkinElmer Inc.
Euroimmun
Eastern Business Forms, Inc.
Ahlstrom
ARCHIMED Life Science GmbH
GenTegra LLC
FortiusBio
CENTOGENE N.V.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Specimen Collection Card market?
What factors are driving Specimen Collection Card market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Specimen Collection Card market opportunities vary by end market size?
How does Specimen Collection Card break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook